does copay actually matter or is it forum lore at this point
Trying to settle this properly because the thread from last year went in circles. The claim: external review matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 18 months without either producing anything. What would actually settle it is 3 people measuring the…
Half-life is about 168 hours, so steady state lands around week 2–5. Practical consequence: what you feel in week 1 is not what that dose does.
Half-life is about 168 hours, so steady state lands around week 2–5.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
external review is the appeal after insurance says no
Strongly agree. Step therapy is predictable if you have the criteria.
formulary exclusions are negotiable sometimes
Removed a chain here. The rule is one line long and it is not negotiable.
Sceptical. If this were true we would see it reflected in the data and we do not.
prior auth criteria are state-specific, appeal differs